Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Arch Dermatol. 2011 Nov 21;148(3):317–322. doi: 10.1001/archdermatol.2011.342

Table 2.

Number and type of immunomodulators used for AM + IM group

Medication Never Past Current Total
Methotrexate 7 4 5 16
Azathioprine 8 1 5 14
Mycophenolate 8 2 8 18
Rituximab 1 0 0 1
Thalidomide 4 1 4 9
Oral corticosteroids 22 4 9 35
Dapsone 2 1 1 4
Cyclophosphamide 1 0 0 1
Lenalidomide 0 0 1 1